These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34973408)

  • 21. Lateral drug diffusion in human nails.
    Palliyil BB; Li C; Owaisat S; Lebo DB
    AAPS PharmSciTech; 2014 Dec; 15(6):1429-38. PubMed ID: 24970585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
    Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
    Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
    Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
    Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciclopirox and Efinaconazole Transungual Permeation, Antifungal Activity, and Proficiency To Induce Resistance in Trichophyton rubrum.
    Monti D; Mazzantini D; Tampucci S; Vecchione A; Celandroni F; Burgalassi S; Ghelardi E
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydration of nail plate: a novel screening model for transungual drug permeation enhancers.
    Chouhan P; Saini TR
    Int J Pharm; 2012 Oct; 436(1-2):179-82. PubMed ID: 22705091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue.
    Aslam R; Hussain T; Yousaf AM; Ghori MU; Khan IU; Rizvi SAA; Shahzad Y
    Curr Drug Res Rev; 2021; 13(1):25-35. PubMed ID: 32735534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active-controlled study and in vitro assays.
    Sigurgeirsson B; Ghannoum MA; Osman-Ponchet H; Kerrouche N; Sidou F
    Mycoses; 2016 May; 59(5):319-26. PubMed ID: 26867498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing the nail permeability of topically applied drugs.
    Murdan S
    Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis.
    Tanrıverdi ST; Özer Ö
    Eur J Pharm Sci; 2013 Mar; 48(4-5):628-36. PubMed ID: 23295582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Patents on Permeation Enhancers for Drug Delivery Through Nails.
    Kreutz T; de Matos SP; Koester LS
    Recent Pat Drug Deliv Formul; 2019; 13(3):203-218. PubMed ID: 31663846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.
    Subissi A; Monti D; Togni G; Mailland F
    Drugs; 2010 Nov; 70(16):2133-52. PubMed ID: 20964457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation.
    Monti D; Saccomani L; Chetoni P; Burgalassi S; Tampucci S; Mailland F
    Br J Dermatol; 2011 Jul; 165(1):99-105. PubMed ID: 21410668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis.
    Turner R; Weaver S; Caserta F; Brown MB
    Int J Pharm Compd; 2016; 20(1):71-80. PubMed ID: 27125057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into drug delivery across the nail plate barrier.
    Saner MV; Kulkarni AD; Pardeshi CV
    J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.
    Täuber A; Müller-Goymann CC
    Mol Pharm; 2014 Jul; 11(7):1991-6. PubMed ID: 24490976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ungual and transungual drug delivery.
    Shivakumar HN; Juluri A; Desai BG; Murthy SN
    Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transungual permeation: current insights.
    Bhuptani RS; Deshpande KM; Patravale VB
    Drug Deliv Transl Res; 2016 Aug; 6(4):426-39. PubMed ID: 26419676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
    Gupta AK; Pillai R
    J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs.
    Kobayashi Y; Komatsu T; Sumi M; Numajiri S; Miyamoto M; Kobayashi D; Sugibayashi K; Morimoto Y
    Eur J Pharm Sci; 2004 Mar; 21(4):471-7. PubMed ID: 14998577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A strong, silk protein-inspired tissue adhesive with an enhanced drug release mechanism for transdermal drug delivery.
    Song H; Wang L; Wu J; Liu J; Liu C; Guo J; Fang L
    Acta Biomater; 2024 Jun; 181():133-145. PubMed ID: 38641185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.